Really shows how people can look at the same event and numbers, listen to the conference call, and see 2 very different companies coming out of it.
Some, like you, see junk now. Some, like me, see the same great company expanding their retail footprint and positioning for explosive revenue growth when the FDA issues a legal framework.
To each their own.